BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17137311)

  • 1. Medium term planning of biopharmaceutical manufacture with uncertain fermentation titers.
    Lakhdar K; Farid SS; Titchener-Hooker NJ; Papageorgiou LG
    Biotechnol Prog; 2006; 22(6):1630-6. PubMed ID: 17137311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medium term planning of biopharmaceutical manufacture using mathematical programming.
    Lakhdar K; Zhou Y; Savery J; Titchener-Hooker NJ; Papageorgiou LG
    Biotechnol Prog; 2005; 21(5):1478-89. PubMed ID: 16209554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiobjective long-term planning of biopharmaceutical manufacturing facilities.
    Lakhdar K; Savery J; Papageorgiou LG; Farid SS
    Biotechnol Prog; 2007; 23(6):1383-93. PubMed ID: 17924645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of rifamycin B fermentation in shake flasks via a machine-learning-based approach.
    Bapat PM; Wangikar PP
    Biotechnol Bioeng; 2004 Apr; 86(2):201-8. PubMed ID: 15052640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of agent-based system for bioprocess description and process improvement.
    Gao Y; Kipling K; Glassey J; Willis M; Montague G; Zhou Y; Titchener-Hooker NJ
    Biotechnol Prog; 2010; 26(3):706-16. PubMed ID: 20014420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Building biomanufacturing capacity--the chapter and verse.
    Kamarck ME
    Nat Biotechnol; 2006 May; 24(5):503-5. PubMed ID: 16680126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Throughput Optimization of Continuous Biopharmaceutical Manufacturing Facilities.
    Garcia FA; Vandiver MW
    PDA J Pharm Sci Technol; 2017; 71(3):189-205. PubMed ID: 27974629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case study and application of process analytical technology (PAT) towards bioprocessing: use of on-line high-performance liquid chromatography (HPLC) for making real-time pooling decisions for process chromatography.
    Rathore AS; Yu M; Yeboah S; Sharma A
    Biotechnol Bioeng; 2008 Jun; 100(2):306-16. PubMed ID: 18078292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capacity planning for batch and perfusion bioprocesses across multiple biopharmaceutical facilities.
    Siganporia CC; Ghosh S; Daszkowski T; Papageorgiou LG; Farid SS
    Biotechnol Prog; 2014; 30(3):594-606. PubMed ID: 24376262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A decision-support model for evaluating changes in biopharmaceutical manufacturing processes.
    Chhatre S; Francis R; O'Donovan K; Titchener-Hooker NJ; Newcombe AR; Keshavarz-Moore E
    Bioprocess Biosyst Eng; 2007 Jan; 30(1):1-11. PubMed ID: 17093973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A genetic algorithm-based area coverage approach for controlled drug delivery using microrobots.
    Tao W; Zhang M
    Nanomedicine; 2005 Mar; 1(1):91-100. PubMed ID: 17292063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization strategies based on sequential quadratic programming applied for a fermentation process for butanol production.
    Pinto Mariano A; Bastos Borba Costa C; de Franceschi de Angelis D; Maugeri Filho F; Pires Atala DI; Wolf Maciel MR; Maciel Filho R
    Appl Biochem Biotechnol; 2009 Nov; 159(2):366-81. PubMed ID: 19082763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal design of protein production plants with time and size factor process models.
    Montagna JM; Vecchietti AR; Iribarren OA; Pinto JM; Asenjo JA
    Biotechnol Prog; 2000; 16(2):228-37. PubMed ID: 10753448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The state of biopharmaceutical manufacturing.
    Molowa DT; Mazanet R
    Biotechnol Annu Rev; 2003; 9():285-302. PubMed ID: 14650933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biopharmaceutical proteins: opportunities and challenges.
    Birch JR; Onakunle Y
    Methods Mol Biol; 2005; 308():1-16. PubMed ID: 16082021
    [No Abstract]   [Full Text] [Related]  

  • 16. Decision-support tool for assessing biomanufacturing strategies under uncertainty: stainless steel versus disposable equipment for clinical trial material preparation.
    Farid SS; Washbrook J; Titchener-Hooker NJ
    Biotechnol Prog; 2005; 21(2):486-97. PubMed ID: 15801789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Particle competition for complex network community detection.
    Quiles MG; Zhao L; Alonso RL; Romero RA
    Chaos; 2008 Sep; 18(3):033107. PubMed ID: 19045445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the optimal design of the disassembly and recovery processes.
    Xanthopoulos A; Iakovou E
    Waste Manag; 2009 May; 29(5):1702-11. PubMed ID: 19138507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MAGDM linear-programming models with distinct uncertain preference structures.
    Xu ZS; Chen J
    IEEE Trans Syst Man Cybern B Cybern; 2008 Oct; 38(5):1356-70. PubMed ID: 18784017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Productivity improvement of recombinant Escherichia coli fermentation via robust optimization.
    Kavanagh JM; Barton GW
    Bioprocess Biosyst Eng; 2008 Feb; 31(2):137-43. PubMed ID: 17717709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.